PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 3.5 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Centenial Surgical Suture Ltd reported revenue from operations of ₹5,351.62 lakhs for FY25, up about 4.6% from ₹5,118.89 lakhs in FY24. However, the company swung to a net loss of ₹146.37 lakhs in FY25 versus a profit of ₹113.44 lakhs in FY24, translating to a loss per share of ₹4.01 against EPS of ₹3.11 previously. The swing to losses was driven by a sharp jump in depreciation (from ₹138.79 to ₹425.46 lakhs) and higher finance costs (from ₹246.89 to ₹374.55 lakhs), suggesting recent heavy capex and debt. Operating cash flow, however, remained healthy at ₹1,707.40 lakhs versus ₹621.47 lakhs in FY24. Total assets rose to ₹8,458.47 lakhs while equity dipped to ₹3,075.49 lakhs, and non-current financial liabilities climbed to ₹2,200 lakhs from ₹1,396 lakhs a year ago. The statutory auditor issued an unmodified (clean) opinion on the results.
Despite modest revenue growth, shareholders face a clear swing into net losses driven by higher depreciation and finance costs, while equity has eroded slightly — likely weighing on the stock in the near term despite strong operating cash generation.